The vaginal microbiome as a predictor for outcome of in vitro fertilization with or without intracytoplasmic sperm injection: A prospective study

STUDY QUESTION: Is the presence or absence of certain vaginal bacteria associated with failure or success to become pregnant after an in vitro fertilization (IVF) or IVF with intracytoplasmic sperm injection (IVF-ICSI) treatment? SUMMARY ANSWER: Microbiome profiling with the use of interspace profiling (IS-pro) technique enables stratification of the chance of becoming pregnant prior to the start of an IVF or IVF-ICSI treatment. WHAT IS KNOWN ALREADY: Live-birth rates for an IVF or IVF-ICSI treatment vary between 25 and 35% per cycle and it is difficult to predict who will or will not get preg... Mehr ...

Verfasser: Koedooder, R.
Singer, M.
Schoenmakers, S.
Savelkoul, P. H.M.
Morré, S. A.
De Jonge, J. D.
Poort, L.
Cuypers, W. J.S.S.
Beckers, N. G.M.
Broekmans, F. J.M.
Cohlen, B. J.
Den Hartog, J. E.
Fleischer, K.
Lambalk, C. B.
Smeenk, J. M.J.S.
Budding, A. E.
Laven, J. S.E.
Dokumenttyp: Artikel
Erscheinungsdatum: 2019
Schlagwörter: Adult / Birth Rate / Clinical Decision-Making/methods / DNA / Bacterial/isolation & purification / Embryo Transfer/statistics & numerical data / Female / Germany / Humans / Infertility / Female/therapy / Lactobacillus crispatus/genetics / Microbiota / Models / Statistical / Netherlands / Predictive Value of Tests / Pregnancy / Prospective Studies / RNA / Ribosomal / 16S/genetics / Risk Assessment/methods / Sperm Injections / Intracytoplasmic/statistics & numerical data / Time Factors / Treatment Outcome / Vagina/microbiology / Journal Article / Multicenter Study / Research Support / Non-U.S. Gov't / Validation Studies
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-28790692
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://dspace.library.uu.nl/handle/1874/438995

STUDY QUESTION: Is the presence or absence of certain vaginal bacteria associated with failure or success to become pregnant after an in vitro fertilization (IVF) or IVF with intracytoplasmic sperm injection (IVF-ICSI) treatment? SUMMARY ANSWER: Microbiome profiling with the use of interspace profiling (IS-pro) technique enables stratification of the chance of becoming pregnant prior to the start of an IVF or IVF-ICSI treatment. WHAT IS KNOWN ALREADY: Live-birth rates for an IVF or IVF-ICSI treatment vary between 25 and 35% per cycle and it is difficult to predict who will or will not get pregnant after embryo transfer (ET). Recently, it was suggested that the composition of the vaginal microbiota prior to treatment might predict pregnancy outcome. Analysis of the vaginal microbiome prior to treatment might, therefore, offer an opportunity to improve the success rate of IVF or IVF-ICSI. STUDY DESIGN, SIZE, DURATION: In a prospective cohort study, 303 women (age, 20-42 years) undergoing IVF or IVF-ICSI treatment in the Netherlands were included between June 2015 and March 2016. PARTICIPANTS/MATERIALS, SETTING, METHODS: Study subjects provided a vaginal sample before the start of the IVF or IVF-ICSI procedure. The vaginal microbiota composition was determined using the IS-pro technique. IS-pro is a eubacterial technique based on the detection and categorization of the length of the 16S-23S rRNA gene interspace region. Microbiome profiles were assigned to community state types based on the dominant bacterial species. The predictive accuracy of the microbiome profiles for IVF and IVF-ICSI outcome of fresh ET was evaluated by a combined prediction model based on a small number of bacterial species. From this cohort, a model was built to predict outcome of fertility treatment. This model was externally validated in a cohort of 50 women who were undergoing IVF or IVF-ICSI treatment between March 2018 and May 2018 in the Dutch division of the MVZ VivaNeo Kinderwunschzentrum Düsseldorf, Germany. MAIN RESULTS AND THE ROLE ...